Danaher Corporation (NYSE:DHR) is one of the Best Stocks to Buy Before the Next Bull Run . On April 22, Morgan Stanley ...

At Danaher Corporation’s annual meeting of shareholders held on May 5, 2026, investors elected eleven directors to serve terms expiring in 2027, with each nominee receiving substantial majority ...

Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

If biotech funding continues to increase this year, Danaher could benefit.

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...

Masimo (Nasdaq:MASI) announced today that its shareholders voted in favor of the proposed acquisition of the company by ...

Biotech funding has been in a down cycle for roughly the past four years. Higher interest rates, tighter capital markets, and a collapse in funding after 2021 forced a lot of early stage biotech ...

Danaher started out as an aggressive corporate raider, but an encounter with Warren Buffett led to a more patient and ...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada ...

Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect ...